×
About 3,710 results

ALLMedicine™ Bacterial Vaginosis Center

Research & Reviews  1,102 results

Single-Dose Clindamycin Gel Highly Effective for Bacterial Vaginosis.
https://doi.org/10.1001/jama.2022.10377
JAMA Slomski A

Jun 29th, 2022 - Single-Dose Clindamycin Gel Highly Effective for Bacterial Vaginosis.|2022|Slomski A,|

Screening for low-tract genital infections in women with threatened preterm labour. Whi...
https://doi.org/10.1159/000525245
Gynecologic and Obstetric Investigation; Sileo FG, Inversetti A et. al.

Jun 23rd, 2022 - to evaluate the possible relationship between cultural specimens and preterm birth in women admitted for threatened preterm labour. Preterm birth is the leading cause of neonatal mortality and antenatal hospitalization: several risk factors includ...

Is there any association between adherence to the Mediterranean Diet and Dietary Total ...
https://doi.org/10.1186/s12905-022-01833-8 10.3389/fimmu.2019.02034 10.1038/srep11640 10.1016/j.cub.2014.03.034 10.1111/and.13624 10.1186/1741-7015-12-112 10.18632/oncotarget.13553 10.1016/j.amjmed.2014.10.014 10.1096/fj.06-6328com 10.3390/ijms19030686 10.1108/NFS-10-2019-0322 10.1021/jf0256541 10.2174/0929867043455567 10.1007/s00394-015-0840-2 10.1155/2022/1225544 10.1186/s12978-019-0814-6 10.1186/s12978-019-0814-6 10.1016/j.ajog.2019.01.229 10.1093/jn/137.9.2128 10.3945/jn.111.140541 10.1128/jcm.29.2.297-301.1991 10.1155/2005/230319 10.1017/S1368980009991698 10.1093/jn/138.2.358 10.1080/09637486.2017.1287884 10.1016/j.foodchem.2004.11.033 10.5812/ircmj.37698 10.1080/10942912.2012.680221 10.1016/S0140-6736(07)60917-9 10.1111/1541-4337.12193 10.1079/BJN20041130 10.1001/jama.292.7.828 10.1177/0148607104028005348 10.1097/00000658-200212000-00014 10.1007/s00011-009-0077-8 10.1111/jam.13054 10.1128/AEM.02200-17 10.1086/430926 10.3390/nu5010234 10.1038/nature11319 10.1097/00004836-200603000-00015 10.3389/fimmu.2017.00548 10.1016/j.appet.2010.01.018 10.2337/diacare.28.6.1397 10.1017/S002966511000162X 10.1186/1471-2334-5-55 10.1016/S0899-9007(01)00649-9 10.1079/BJN2000297 10.3390/nu8020089 10.4103/0972-2327.120429 10.2147/JMDH.S104807
BMC Women's Health; Noormohammadi M, Eslamian G et. al.

Jun 21st, 2022 - Bacterial vaginosis, BV, is a common inflammatory vaginal dysbiosis. The Mediterranean diet, MD, containing foods rich in antioxidant compounds, is shown to be beneficial for inflammatory conditions. This study aimed to investigate the association...

The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persist...
https://doi.org/10.1016/j.currproblcancer.2022.100877
Current Problems in Cancer; Alimena S, Davis J et. al.

Jun 17th, 2022 - The purpose of this review is to describe the existing literature regarding the relationship between the vaginal microbiome, human papillomavirus persistence, and cervical cancer risk, as well as to discuss factors that mediate these relationships...

see more →

Guidelines  8 results

Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US P...
https://doi.org/10.1001/jama.2020.2684
JAMA , Owens DK et. al.

Apr 8th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...

No. 211-Screening and Management of Bacterial Vaginosis in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.04.018
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Yudin MH, Money DM

Jul 22nd, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...

Adolescent Pregnancy Guidelines.
https://doi.org/10.1016/S1701-2163(15)30180-8
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Fleming N, O'Driscoll T et. al.

Oct 17th, 2015 - To describe the needs and evidence-based practice specific to care of the pregnant adolescent in Canada, including special populations. Healthy pregnancies for adolescent women in Canada, with culturally sensitive and age-appropriate care to ensur...

Cervical insufficiency and cervical cerclage.
https://doi.org/10.1016/S1701-2163(15)30764-7
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Brown R, Gagnon R et. al.

Jan 11th, 2014 - The purpose of this guideline is to provide a framework that clinicians can use to determine which women are at greatest risk of having cervical insufficiency and in which set of circumstances a cerclage is of potential value. Published literature...

European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011.
https://doi.org/10.1258/ijsa.2011.011012
International Journal of STD & AIDS; Sherrard J, Donders G et. al.

Jul 29th, 2011 - Three common infections are associated with vaginal discharge: bacterial vaginosis, trichomoniasis and candidiasis, of which trichomoniasis is a sexually transmitted infection (STI). This guideline covers the presentation and clinical findings of ...

see more →

Drugs  43 results see all →

Clinicaltrials.gov  187 results

Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy
https://clinicaltrials.gov/ct2/show/NCT02288832

Jun 13th, 2022 - The principal objective is to use a cost-effectiveness study to assess the medical and economic impact of a new strategy for the screening and subsequent treatment of vaginal flora anomalies before the 20th week of gestation- molecular biology tec...

Suppression Of Bacterial Vaginosis (BV) [SUBVert]
https://clinicaltrials.gov/ct2/show/NCT03930745

Jun 13th, 2022 - This is a Phase II randomized, double-blind, placebo-controlled study screening approximately 600 adult females, aged 18-55, with a goal to enroll approximately 250 participants to achieve 200 evaluable participants at the test of cure (TOC) visit...

Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
https://clinicaltrials.gov/ct2/show/NCT03261804

May 25th, 2022 - The actual frequency of infectious vaginitis is difficult to determine, due to numerous confounding factors, such as a high asymptomatic rate, inaccurate self-diagnosis and treatment, and population dependence. In the USA, the prevalence of cervic...

Flourish Vaginal Care System to Establish Neovaginal Microbiome
https://clinicaltrials.gov/ct2/show/NCT05372770

May 13th, 2022 - Very little is known about the neovaginal microbiome, but it has been described as being a polymicrobial state similar to bacterial vaginosis (BV) in cis women. The Flourish Vaginal Care System is a commercially-available over-the-counter vaginal ...

A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH
https://clinicaltrials.gov/ct2/show/NCT05060029

May 2nd, 2022 - The vaginal microbiome is said to be the first line of defence against vaginal infection, due to competitive exclusion and the destruction of pathogenic microbes. The vagina remains relatively sterile until a woman reaches puberty, after which the...

see more →

News  135 results

Treatment for BV, trichomoniasis approved for adolescents
https://www.mdedge.com/obgyn/article/251982/gynecology/treatment-bv-trichomoniasis-approved-adolescents
Jake Remaly

Feb 18th, 2022 - The Food and Drug Administration has approved secnidazole for the treatment of bacterial vaginosis (BV) and trichomoniasis in patients aged 12 years and older. The antimicrobial agent, marketed as Solosec, was first approved in 2017 as a treatment.

FDA Approves Secnidazole for BV, Trichomoniasis in Adolescents
https://www.medscape.com/viewarticle/968853

Feb 18th, 2022 - The Food and Drug Administration has approved secnidazole for the treatment of bacterial vaginosis (BV) and trichomoniasis in patients aged 12 years and older. The antimicrobial agent, marketed as Solosec, was first approved in 2017 as a treatment...

Oral Metronidazole Vs Intravaginal Lactic Acid Gel for Bacterial Vaginosis
https://www.medscape.com/viewarticle/967889

Feb 4th, 2022 - Takeaway Participants with recurrent bacterial vaginosis demonstrated a significantly higher treatment response to oral metronidazole than to intravaginal lactic acid gel at 2 weeks, but treatment failure was common in both groups. Metronidazole w...

Infectious disease pop quiz: Clinical challenge #12 for the ObGyn
https://www.mdedge.com/obgyn/article/251245/mixed-topics/infectious-disease-pop-quiz-clinical-challenge-12-obgyn
Emily Susan Edwards, MD, MS, Patrick Duff, MD

Jan 28th, 2022 - What are the best office-based tests for the diagnosis of bacterial vaginosis? Continue to the answer.

Secnidazole gets FDA nod for trichomoniasis
https://www.mdedge.com/infectiousdisease/article/242489/stis/secnidazole-gets-fda-nod-trichomoniasis
Heidi Splete

Jul 2nd, 2021 - The Food and Drug Administration has expanded the approval of secnidazole to include treatment of trichomoniasis in adults, according to a statement from manufacturer Lupin Pharmaceuticals. Trichomoniasis vaginalis is a common, nonviral, curable s.

see more →

Patient Education  9 results see all →